Wanbury Ltd
Ticker: WANBURY
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
241.25
Market Cap
841.41
Debt/Equity
3.0172
ROE %
69.984
PB
14.1962
Promoter %
43.093
Pledge %
26.797
1Y Rev Growth %
-0.199
5Y Rev Growth %
5.970
NP Margin %
5.061
NP Margin 5Y Avg %
4.578
Trading Reference
1M Return %
-5.553
6M Return %
-5.050
1Y Return %
-2.996
% Away 52W High
36.663
% Away 52W Low
56.646
Daily Volume
108565
Investment Verdict
Avoid
Score 33/100 · Position size: 0%
Fundamentals/valuations or risk flags are weak. Avoid for long-term investing.
Trading Verdict
Avoid
Score 11/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
More Options
A
Arrow Greentech Ltd
Arrow Greentech Ltd shows potential in a growing sector but faces challenges in consistency and valuation.
View details
A
Andhra Cements Ltd
Andhra Cements Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
L
Laxmi India Finance Ltd
Laxmi India Finance Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
E
Essen Speciality Films Ltd
Essen Speciality Films Ltd has a decent outlook with growth potential, but faces challenges in profitability and execution risks.
View details
V
Veefin Solutions Ltd
Veefin Solutions Ltd shows potential in a growing sector but faces significant risks and inconsistencies in growth and profitability.
View details
V
Viviana Power Tech Ltd
Viviana Power Tech Ltd shows potential in a growing sector but faces significant challenges in profitability and valuation metrics. Caution is advised for investors.
View details
Z
Z-Tech (India) Ltd
Z-Tech (India) Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised.
View details
J
Jaiprakash Associates Ltd
Jaiprakash Associates Ltd presents a risky investment with several challenges in growth and profitability metrics, alongside high debt levels.
View details
N
NINtec Systems Ltd
NINtec Systems Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns.
View details
V
Voith Paper Fabrics India Ltd
Voith Paper Fabrics India Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in performance metrics, making it a risky investment at this time.
View details
A
Anand Rayons Ltd
Anand Rayons Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Satia Industries Ltd
Satia Industries Ltd shows decent fundamentals but faces challenges in profitability and growth drivers. Caution is advised.
View details
M
Mukka Proteins Ltd
Mukka Proteins Ltd shows potential but faces several challenges that could impact future performance.
View details
B
Bodal Chemicals Ltd
Bodal Chemicals Ltd shows potential in a growing sector, but faces challenges in consistency and execution. Caution is advised.
View details
O
OBSC Perfection Ltd
OBSC Perfection Ltd shows some potential but faces significant challenges in growth and profitability metrics. Caution is advised.
View details
E
Eraaya Lifespaces Ltd
While Eraaya Lifespaces Ltd shows potential in a growing sector, inconsistencies in financial performance and valuation concerns warrant caution.
View details
Business Overview
Wanbury Ltd is a prominent Indian pharmaceutical company dedicated to improving healthcare through innovative solutions. With a strong focus on quality and affordability, Wanbury caters to a diverse range of therapeutic areas, making healthcare accessible for all. The company's commitment to research and development ensures that it stays at the forefront of medical advancements, benefiting patients and healthcare providers alike.
- Established player in the Indian pharmaceutical sector
- Focus on quality and affordability
- Diverse therapeutic portfolio
- Strong commitment to research and development
- Enhancing healthcare accessibility for all
- Trusted by healthcare professionals across India
Investment Thesis
Wanbury Ltd stands out as a compelling investment due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. These factors position the company for sustainable growth and enhanced shareholder value.
- Strong promoter group with a solid track record in the pharmaceutical sector.
- Expanding digital services division poised for substantial growth.
- Valuation metrics indicate Wanbury is undervalued compared to industry peers.
- Focus on innovation and R&D to drive future revenue streams.
- Robust financial health supports long-term strategic initiatives.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceuticals
- Expansion into new markets
- Strong product pipeline
- Strategic partnerships with distributors
Risks ⚠️
- Regulatory changes in healthcare
- Intense competition in sector
- Supply chain disruptions
- Dependence on key clients
Peer Perspective
Wanbury Ltd trades at a discount to peers like Sun Pharma and Aurobindo Pharma, primarily due to margin volatility. A stable margin profile could trigger a rerating, aligning its valuation closer to industry averages.
Future Outlook
Wanbury Ltd is poised for growth, driven by its innovative product pipeline and expanding market presence. However, successful execution and stringent cost control will be crucial to achieving sustainable profitability.
📊 Stock Investment Checklist (100 Points)
Wanbury Ltd • Updated: 2025-09-18 09:30:09
-
8BusinessHighPharmaceutical sector shows potential but faces regulatory challenges.
-
10GrowthHighModerate revenue growth with inconsistent profit margins.
-
10ProfitabilityHighROE and ROCE are below industry averages.
-
9ValuationHighP/E ratio is higher than peers, indicating potential overvaluation.
-
6BalanceGoodDebt levels are manageable but liquidity is a concern.
-
7GovernanceHighPromoter holding is decent, but some pledging exists.
-
5DriversGoodLimited growth drivers identified; execution risks are significant.
-
1TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Wanbury Ltd presents several risks with limited growth prospects and high valuation metrics, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100